Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, PhaseⅢ Study to Evaluate the Efficacy and Safety of MRA in Patients With RA

NCT00380601 is registered in ClinicalTrials.gov with Chugai Pharmaceutical as lead sponsor.

NCT NCT00380601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00380601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, PhaseⅢ Study to Evaluate the Efficacy and Safety of MRA in Patients With RA
Lead sponsor
Chugai Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
February 28, 2009
Enrollment
20 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis